Docetaxel and Carboplatin With or Without Trastuzumab Before Surgery in Treating Women With Locally Advanced Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: BIOLOGICAL: trastuzumab|DRUG: carboplatin|DRUG: docetaxel|BIOLOGICAL: trastuzumab
Sponsor: Jonsson Comprehensive Cancer Center
Collaborators: Aventis Pharmaceuticals|Genentech, Inc.